Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost vs Timolol in Pediatric Glaucoma
NCT00716859Phase 3Completed
- Sponsor
- Viatris
- Start
- Jul 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of latanoprost ophthalmic solution 0.005% (TearClear TC-002) in Glaucoma, sponsored by Viatris. Started Jul 2008; status: completed.
02
Drugs
latanoprost ophthalmic solution 0.005% (TearClear TC-002)
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00716859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716859.